Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)
Egypt flag Egypt · Delayed Price · Currency is EGP
80.77
+1.22 (1.53%)
At close: Mar 27, 2025

EGX:MPCI Revenue

Memphis Pharmaceuticals & Chemical Industries had revenue of 388.26M EGP in the quarter ending December 31, 2024, with 57.10% growth. This brings the company's revenue in the last twelve months to 1.23B, up 55.51% year-over-year. In the fiscal year ending June 30, 2024, Memphis Pharmaceuticals & Chemical Industries had annual revenue of 871.91M with 31.34% growth.

Revenue (ttm)
1.23B
Revenue Growth
+55.51%
P/S Ratio
0.37
Revenue / Employee
8.54M
Employees
144
Market Cap
1.84B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2024871.91M208.07M31.34%
Jun 30, 2023663.83M112.57M20.42%
Jun 30, 2022551.26M33.15M6.40%
Jun 30, 2021518.11M29.70M6.08%
Jun 30, 2020488.41M125.34M34.52%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition